Is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid?
Publication
, Journal Article
Elmore, SA; Rehg, JE; Schoeb, TR; Everitt, JI; Bolon, B
Published in: Toxicol Sci
September 28, 2023
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Toxicol Sci
DOI
EISSN
1096-0929
Publication Date
September 28, 2023
Volume
195
Issue
2
Start / End Page
143 / 144
Location
United States
Related Subject Headings
- Toxicology
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Elmore, S. A., Rehg, J. E., Schoeb, T. R., Everitt, J. I., & Bolon, B. (2023). Is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid? Toxicol Sci, 195(2), 143–144. https://doi.org/10.1093/toxsci/kfad070
Elmore, Susan A., Jerold E. Rehg, Trenton R. Schoeb, Jeffrey I. Everitt, and Brad Bolon. “Is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid?” Toxicol Sci 195, no. 2 (September 28, 2023): 143–44. https://doi.org/10.1093/toxsci/kfad070.
Elmore SA, Rehg JE, Schoeb TR, Everitt JI, Bolon B. Is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid? Toxicol Sci. 2023 Sep 28;195(2):143–4.
Elmore, Susan A., et al. “Is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid?” Toxicol Sci, vol. 195, no. 2, Sept. 2023, pp. 143–44. Pubmed, doi:10.1093/toxsci/kfad070.
Elmore SA, Rehg JE, Schoeb TR, Everitt JI, Bolon B. Is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid? Toxicol Sci. 2023 Sep 28;195(2):143–144.
Published In
Toxicol Sci
DOI
EISSN
1096-0929
Publication Date
September 28, 2023
Volume
195
Issue
2
Start / End Page
143 / 144
Location
United States
Related Subject Headings
- Toxicology
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences